stride semaglutide boosts walking ability in diabetes patients with peripheral artery disease, clinical trial finds Benefit of Semaglutide in PAD

Demura Y et al

Medical Conditions: Conditions like acid reflux, GERD, or diabetes can falsely elevate breath test readings

In one study, 12-week treatment with insulin glargine vs liraglutide (mean dose = 1.3 mg/day) showed similar glycemic control and decrease of hepatic fat burden, although a reduction in BMI was only observed in the liraglutide-treated patients (68)

Its not a short-term fix, its part of a long-term, sustainable plan." Key Insight: Addressing misconceptions helps patients feel informed, reduces uncertainty, and encourages engagement and adherence

GLP-1 users carry a much higher risk of having retained stomach contents get into the lungs during sedation due to the drug's ability to slow gastric emptying